Literature DB >> 8369891

Transition questions to assess outcomes in rheumatoid arthritis.

R Fitzpatrick1, S Ziebland, C Jenkinson, A Mowat, A Mowat.   

Abstract

The importance of patient-based assessments of outcomes of care in RA is increasingly recognized. There are a number of methods of gaining such data. One method is to request patients to assess change in health status by means of transition questions. This is considered advantageous to other methods because is directly addresses perceptions of change over time and is short and simple. One hundred patients with RA completed a range of clinical, laboratory and health status assessments on two occasions 3 months apart. On the second occasion they also completed a transition question. Results show the question to be valid and to correlate with a number of different changes obtained from assessments. Psychological mood did not appear to influence transition judgements. A small minority of patients experienced changes for specific dimensions of health status in the opposite direction of the transition item. Transition judgements may have an important role in evaluation studies and audit.

Entities:  

Mesh:

Year:  1993        PMID: 8369891     DOI: 10.1093/rheumatology/32.9.807

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  13 in total

1.  Danish version of the Oswestry disability index for patients with low back pain. Part 2: Sensitivity, specificity and clinically significant improvement in two low back pain populations.

Authors:  Henrik Hein Lauridsen; Jan Hartvigsen; Claus Manniche; Lars Korsholm; Niels Grunnet-Nilsson
Journal:  Eur Spine J       Date:  2006-05-31       Impact factor: 3.134

2.  SF 36 health survey questionnaire: II. Responsiveness to changes in health status in four common clinical conditions.

Authors:  A M Garratt; D A Ruta; M I Abdalla; I T Russell
Journal:  Qual Health Care       Date:  1994-12

Review 3.  Appraisal assessment in patient-reported outcome research: methods for uncovering the personal context and meaning of quality of life.

Authors:  Carolyn E Schwartz; Joel A Finkelstein; Bruce D Rapkin
Journal:  Qual Life Res       Date:  2016-12-17       Impact factor: 4.147

4.  Comparison of measures to assess outcomes in total hip replacement surgery.

Authors:  J Dawson; R Fitzpatrick; D Murray; A Carr
Journal:  Qual Health Care       Date:  1996-06

5.  Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.

Authors:  R Harper; J E Brazier; J C Waterhouse; S J Walters; N M Jones; P Howard
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

6.  Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration.

Authors:  Josephine M Norquist; Ray Fitzpatrick; Crispin Jenkinson
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

7.  Advances in clinical research methodology for pain clinical trials.

Authors:  John T Farrar
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

8.  Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).

Authors:  C Jenkinson; J M Norquist; R Fitzpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

9.  Performance of an item response theory-based computer adaptive test in identifying functional decline.

Authors:  Andrea L Cheville; Kathleen J Yost; Dirk R Larson; Katiuska Dos Santos; Megan M O'Byrne; Megan T Chang; Terry M Therneau; Felix E Diehn; Ping Yang
Journal:  Arch Phys Med Rehabil       Date:  2012-02-25       Impact factor: 3.966

10.  Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; Breanna L Weisbrod; Drew K Seisler; Debra L Barton; Kelliann C Fee-Schroeder; Thomas J Smith; Daniel H Lachance; Heshan Liu; Randy A Shelerud; Andrea L Cheville; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.